Camille L Bedrosian
CIK 1326969 · Chief Medical Officer · last filed 2026-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.28M
Companies
5
Total Filings
44
Lifetime Open-Market Net
-$6.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMLX | Chief Medical Officer | 265,285 | $14.59 | $3.87M | -$473.8K | 10 | 2026-03-09 |
| RYTM | Director | 7,000 | $88.38 | $618.7K | $0 | 8 | 2025-06-26 |
| CRNX | Director | 16,300 | $34.47 | $561.9K | $0 | 6 | 2025-06-13 |
| RARE | EVP and Chief Medical Officer | 50,601 | $24.35 | $1.23M | -$6.04M | 19 | 2023-03-03 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | VP, Chief Medical Officer | — | — | — | $0 | 1 | 2007-04-18 |
Recent Filings · Page 3 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-10 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2022-03-03 | RARE | Mixed | +11,179 | -$187.9K | EDGAR |
| 2022-02-01 | RARE | Sell (S) | −1,657 | -$109.9K | EDGAR |
| 2021-10-18 | RARE | Sell (S) | −359 | -$29.1K | EDGAR |
| 2021-09-02 | RARE | Mixed | — | -$225.5K | EDGAR |
| 2021-06-23 | CRNX | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2021-05-10 | RARE | Sell (S) | −364 | -$41.4K | EDGAR |
| 2021-04-19 | RARE | Mixed | — | -$270.4K | EDGAR |
| 2021-03-03 | RARE | Mixed | +5,593 | -$627.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.